Mechanism-Based Inhibitors of the Aspartyl Protease Plasmepsin II as Potential Antimalarial Agents. (Research article)

​

Journal of Medicinal Chemistry.

​

May 2010, 53, 10, 4234-4247.

​

DOI: 10.1021/jm100233b

Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia. (Research article)

​

Blood.

​

February 2006, 107 (4): 1570-1581.

​

DOI: 10.1182/blood-2005-06-2219